Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Anticancer Drugs. 2013 Mar;24(3):10.1097/CAD.0b013e32835d29fd. doi: 10.1097/CAD.0b013e32835d29fd

Figure 3. The effect of CNTO95 and dasatinib on the migration of HCT-116 cells (A-C) and RKO cells (D-F).

Figure 3

Figure 3

Cell migration upon exposure to various doses of CNTO95 (A, D) or dasatinib (B, E) as single agent treatment was assessed and depicted as percent value of the untreated cells. Quantifications of cell migration are displayed as bar graphs for HCT-116 cells (C) and RKO cells (F). *, significantly different from untreated control, P<0.05; **, significantly different from either drug treatment, P<0.05. Data are shown as the mean ± SD.